Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
M. Sanchez Quiroga (Plasencia, Spain), J. Masa Jiménez (Cáceres, Spain), B. Mokhlesi (Chicago, United States of America), I. Benitez (Lérida, Spain), F. Gómez De Terreros (Cáceres, Spain), A. Romero (Sevilla, Spain), C. Caballero Eraso (Sevilla, Spain), J. Teran Santos (Burgos, Spain), M. Alonso Álvarez (Burgos, Spain), M. Troncoso (Madrid, Spain), M. González (Santander, Spain), S. López Martin (Madrid, Spain), J. Marín (Zaragoza, Spain), S. Marti (Barcelona, Spain), T. Díaz Cambriles (Madrid, Spain), E. Chiner (Alicante, Spain), C. Egea Santaolalla (Vitoria, Spain), J. Barca (Vitoria, Spain), F. Vázquez Polo (Canary Islands, Spain), M. Negrin (Canary Islands, Spain), M. Martel Escobar (Canary Islands, Spain), F. Barbe (Lérida, Spain), J. Corral (Cáceres, Spain). Long-term positive airway pressure therapy in obesity hypoventilation syndrome. Cost study. 2013

Member's Comments

No comment yet.

Related content which might interest you: Efficacy of continous positive airway pressure (CPAP) in the treatment of the obesity hypoventilation syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 726s Year: 2005 Long-term echocardiographic changes with positive airway pressure therapy in obesity hypoventilation syndrome Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020 Long term positive airway pressure effectiveness in obesity hypoventilation syndrome. Pickwick study results Source: International Congress 2018 – Hot topics in non-invasive ventilation Year: 2018 The Pickwick randomized clinical trial: long-term positive airway pressure therapy in obesity hypoventilation syndrome Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation Year: 2019 Obesity hypoventilation syndrome and neurocognitive function - impact of positive airway pressure therapy Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities Year: 2018 Continuous positive airway pressure or NIV in patients with acute and chronic obesity hypoventilation syndrome? Source: Sleep and Breathing Conference 2021 Year: 2021 Effectiveness of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnoea-hypopnoea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 682s Year: 2006 Echocardiographic changes with positive airway pressure in obesity hypoventilation syndrome. Pickwick study Source: International Congress 2017 – CPAP therapy Year: 2017 Falls in blood pressure in patients with obstructive sleep apnea syndrome after long-term nasal continuous positive airway pressure treatment Source: Eur Respir J 2005; 26: Suppl. 49, 38s Year: 2005 Comparative study of a novel positive airway pressure therapy versus conventional AutoCPAP therapy in obstructive sleep apnea syndrome (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 112s Year: 2005 Efficacy of continuous positive airway pressure treatment to resistant hypertension in patients with obstructive sleep apnea syndrome Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008 Long term outcomes of noninvasive positive pressure ventilation for obesity hypoventilation syndrome Source: Annual Congress 2010 - Long-term noninvasive ventilation in the chronic patient: outcome and pathophysiology Year: 2010 Physiological differences in patients with kyphoscoliosis, post tuberculosis sequelae and obesity hypoventilation syndrome when starting long-term noninvasive positive pressure ventilation (NPPV) Source: Annual Congress 2008 - Noninvasive ventilation in the chronic setting Year: 2008 Predictors of compliance with CPAP in patients with OSA and metabolic syndrome Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2009 Impact of continuous positive airway pressure therapy on atrial electromechanical delay in obesity-hypoventilation syndrome patients Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity Year: 2015 Efficacy of continuous positive airway pressure in treatment of patients with bradyarrhythmias associated with obstructive sleep apnoea syndrome Source: Annual Congress 2006 - Cardiovascular consequences of obstructive sleep apnoea Year: 2006 Effect of compliance to continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome Source: Eur Respir J 2007; 30: Suppl. 51, 320s Year: 2007 Predictive factors for stopping use of continuous positive airway pressure (CPAP): an observational cohort of 6938 treated obstructive sleep apnea syndrome (OSAS) patients Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007 Sleep apnoea and systemic hypertension Source: Eur Respir Mon 2010; 50: 150-173 Year: 2010 Management of continuous positive airway pressure treatment compliance using telemonitoring in obstructive sleep apnoea Source: Eur Respir J , 49 (2) 1601128; DOI: 10.1183/13993003.01128-2016 Year: 2017